findmyKOL
Clinical trialNCT03391804CompletedPhase 2Interventional

Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

SponsorAllena PharmaceuticalsEnrollment15Enteric HyperoxaluriaHyperoxalemiaPrimary Hyperoxaluria
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Charite Campus Berlin-Mitte, Medizinische Klinik Mit Schwepunkt Nephrologie Und Internistische Intensivmedizin

    Berlin, Germany

United Kingdom
  • Wellcome Trust Clinical Research Facility

    Southampton, Hampshire, United Kingdom

  • Royal Preston Hospital

    Preston, Lancashire, United Kingdom

  • Leeds General Infirmary

    Leeds, United Kingdom

  • Freeman Hospital

    Newcastle, United Kingdom

United States
  • Mayo Clinic

    Scottsdale, Arizona, United States

  • Applied Research Center of Arkansas

    Little Rock, Arkansas, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jul 2018
Primary completion
13 Dec 2019
Completion
13 Dec 2019
Last update posted
30 Dec 2020
Registered enrollment
15
Registry id
NCT03391804

Cross-registrations

EU-CTR / CTIS (EudraCT)2017-003547-38

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.